US Stock MarketDetailed Quotes

IOVA Iovance Biotherapeutics

Watchlist
  • 8.240
  • +0.100+1.23%
Close Nov 21 16:00 ET
  • 8.100
  • -0.140-1.70%
Post 16:48 ET
2.51BMarket Cap-5567P/E (TTM)

Iovance Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Iovance Biotherapeutics Q3 2024 Earnings Date

Currency：USDNov 7, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
53.82M
58.56M
+4.74M
Beat Est.
+11375.09%
+12385.07%
+8.80%
EPS
-0.30
-0.28
+0.02
Beat Est.
+35.23%
+39.13%
+6.01%
Analyst Rating
Strong Buy

Nov 11, 2024

Iovance Biotherapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 88.588M--
--2024/Q4-- / 71.570M--
Nov 7, 20242024/Q358.555M / 53.818M--
Aug 8, 20242024/Q231.106M / 24.561M--
May 9, 20242024/Q1715.000K / 2.088M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 88.588M--
--2024/Q4-- / 71.570M--
Nov 7, 20242024/Q358.555M / 53.818M--
Aug 8, 20242024/Q231.106M / 24.561M--
May 9, 20242024/Q1715.000K / 2.088M--

Unlock Free Earnings Estimates

Iovance Biotherapeutics Earnings Reports

  • Iovance Biotherapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 8 06:23

  • Iovance Biotherapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 9 05:15

  • Iovance Biotherapeutics | 10-Q: Q1 2024 Earnings Report

    May 10 05:16

  • Iovance Biotherapeutics | 10-K: FY2023 Annual Report

    Feb 29 11:33

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 11, 2024

    Strong Buy

    • Buy

      90.00%

    • Hold

      10.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data